Derivative

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Friday, July 10, 2020 - 3:03pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Friday, July 10, 2020 - 3:03pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

OKChain Testnet Updates to v0.10.9, Spot Leverage Trading and OpenDEX-Desktop Go Live

Friday, July 10, 2020 - 12:02pm

VALLETTA, Malta, July 10, 2020 /PRNewswire/ -- OKChain testnet , the commercial public chain developed by OKEx ( www.okex.com ), a world-leading cryptocurrency spot and derivatives exchange, has recently updated to v0.10.9.

Key Points: 
  • VALLETTA, Malta, July 10, 2020 /PRNewswire/ -- OKChain testnet , the commercial public chain developed by OKEx ( www.okex.com ), a world-leading cryptocurrency spot and derivatives exchange, has recently updated to v0.10.9.
  • At the same time, the OpenDEX-Desktop and UI have gone open-source while the spot leverage trading function has reached 100% completion and OKChainSWAP's model design has also been completed.
  • One of the most eye-catching updates is the spot leverage trading function.
  • We provide spot and derivatives trading including futures, perpetual swap and options of major cryptocurrencies, offering investors flexibility in formulating their strategies to maximize gains and mitigate risks.

OKChain Testnet Updates to v0.10.9, Spot Leverage Trading and OpenDEX-Desktop Go Live

Friday, July 10, 2020 - 11:56am

VALLETTA, Malta, July 10, 2020 /PRNewswire/ -- OKChain testnet , the commercial public chain developed by OKEx ( www.okex.com ), a world-leading cryptocurrency spot and derivatives exchange, has recently updated to v0.10.9.

Key Points: 
  • VALLETTA, Malta, July 10, 2020 /PRNewswire/ -- OKChain testnet , the commercial public chain developed by OKEx ( www.okex.com ), a world-leading cryptocurrency spot and derivatives exchange, has recently updated to v0.10.9.
  • At the same time, the OpenDEX-Desktop and UI have gone open-source while the spot leverage trading function has reached 100% completion and OKChainSWAP's model design has also been completed.
  • One of the most eye-catching updates is the spot leverage trading function.
  • Users now can experience the transaction and wallet functions provided by the okex.com, and issue tokens and trading pairs on the testnet through the desktop.

SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Southern District of Californ

Thursday, July 9, 2020 - 8:54pm

All investors who purchased shares of Sorrento Therapeutics, Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased shares of Sorrento Therapeutics, Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com.
  • If you have incurred losses in the shares of you may, no later than July 27, 2020, request that the Court appoint you lead plaintiff of the proposed class.
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Thursday, July 9, 2020 - 3:09pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Thursday, July 9, 2020 - 3:09pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Wednesday, July 8, 2020 - 6:07pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Wednesday, July 8, 2020 - 6:06pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

KINGOLD JEWELRY, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Southern District of New York  aga

Tuesday, July 7, 2020 - 9:00pm

All investors who purchased shares and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased shares and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com.
  • Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of Kingold Jewelry, Inc.
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.